Abiomed Inc (ABMD) - Product Pipeline Analysis, 2019 Update
August 2019
40
About the Report
About the Report
Summary
Abiomed Inc (Abiomed) provides mechanical circulatory support devices and develops, manufactures and markets novel technologies that replace or assist the pumping function in a failing heart. The company's heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; and percutaneous catheter-based devices including micro heart pumps, expandable catheter pumps and axial flow pumps. Abiomed also offers automated controllers, designed to control and monitor the catheter performance and display real time hemodynamic and catheter position information. It has manufacturing facilities in Danvers, Massachusetts; and Aachen, Germany. The company sells its products through direct sales and distributors in the Americas, Europe, Asia and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Abiomed Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Abiomed Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Getinge AB
Teleflex Inc
Edwards Lifesciences Corp
LivaNova PLC
Boston Scientific Corp
Medtronic Plc
Abbott Laboratories
Terumo Corp
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Abiomed Inc Company Overview
Abiomed Inc Company Snapshot
Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview
Abiomed Inc-Pipeline Analysis Overview
Business Description
Abiomed Inc-Key Facts
Abiomed Inc-Major Products and Services
Abiomed Inc Pipeline Products by Development Stage
Abiomed Inc Ongoing Clinical Trials by Trial Status
Abiomed Inc Pipeline Products Overview
AbioCor II
AbioCor II Product Overview
Impella 5.5
Impella 5.5 Product Overview
Impella BTR
Impella BTR Product Overview
Impella CP (Cardiac Power)
Impella CP (Cardiac Power) Product Overview
Impella CP (Cardiac Power) Clinical Trial
Impella ECP
Impella ECP Product Overview
Next Generation Impella CP-STEMI
Next Generation Impella CP-STEMI Product Overview
Next Generation Impella CP-STEMI Clinical Trial
Symphony Heart Pump
Symphony Heart Pump Product Overview
Abiomed Inc-Key Competitors
Abiomed Inc-Key Employees
Abiomed Inc-Key Employee Biographies
Abiomed Inc-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Abiomed Inc, Recent Developments
Aug 07, 2019: Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed against Abiomed and encourages Abiomed investors to contact the firm
Aug 01, 2019: Abiomed announces Q1 FY 2020 revenue of USD 208 million and 29.2% operating margin
Jun 13, 2019: Impella featured as an innovative technology at U.S. Capitol event showcasing improvements to women's health
May 21, 2019: National Cardiogenic Shock Initiative (NCSI) with impella best practices demonstrates 72% survival with 98% native heart recovery
May 21, 2019: FDA confirms Impella RP is safe and effective; only right-sided device with FDA approval
May 16, 2019: Impella Smartassist platform launches at SCAI, designed to further improve patient outcomes
May 13, 2019: FDA approves Impella 5.0 and Impella LD extended duration of use to 14 days for cardiogenic shock derived from AMI or cardiomyopathy
May 02, 2019: Abiomed announced Q4 FY 2019 revenue of USD 207 million and 31.6% operating margin
May 02, 2019: FDA approves initiation of STEMI DTU Pivotal Randomized Controlled Trial
Apr 30, 2019: Opsens signs landmark supplier agreement-Expands optical sensing technology impact within cardiology segment
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Abiomed Inc Pipeline Products by Equipment Type
Abiomed Inc Pipeline Products by Development Stage
Abiomed Inc Ongoing Clinical Trials by Trial Status
List of Table
List of Tables
Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview
Abiomed Inc Pipeline Products by Equipment Type
Abiomed Inc Pipeline Products by Indication
Abiomed Inc Ongoing Clinical Trials by Trial Status
Abiomed Inc, Key Facts
Abiomed Inc, Major Products and Services
Abiomed Inc Number of Pipeline Products by Development Stage
Abiomed Inc Pipeline Products Summary by Development Stage
Abiomed Inc Ongoing Clinical Trials by Trial Status
Abiomed Inc Ongoing Clinical Trials Summary
AbioCor II-Product Status
AbioCor II-Product Description
Impella 5.5-Product Status
Impella 5.5-Product Description
Impella BTR-Product Status
Impella BTR-Product Description
Impella CP (Cardiac Power)-Product Status
Impella CP (Cardiac Power)-Product Description
Impella CP (Cardiac Power)-A global Initiative in Percutaneous Circulatory Support from the cVAD Steering Committee on Behalf of All cVAD Investigators: Global cVAD Registry
Impella CP (Cardiac Power)-Effects of Advanced Mechanical Circulatory Support in Patients with ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial
Impella CP (Cardiac Power)-Primary Unloading and Delayed Reperfusion in ST-elevation Myocardial Infarction. The STEMI-DTU Pivotal Trial
Impella CP (Cardiac Power)-Pulsecath mechanicaL Support Evaluation (PULSE)-Trial
Impella ECP-Product Status
Impella ECP-Product Description
Next Generation Impella CP-STEMI-Product Status
Next Generation Impella CP-STEMI-Product Description
Next Generation Impella CP-STEMI-A Pivotal, Multi-center, Prospective Study of Impella CP System to Avoid the Development of Heart Failure
Symphony Heart Pump-Product Status
Symphony Heart Pump-Product Description
Abiomed Inc, Key Employees
Abiomed Inc, Key Employee Biographies
Abiomed Inc, Subsidiaries
Glossary
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.